Derma Sciences
Muhammad Haseeb's work experience includes serving as the Chief Executive Officer for Al Haseeb Group and companies starting in January 2018. Prior to that, they were the Chief Executive Officer for Derma Sciences starting in January 2015. Muhammad also held a position as Director for SB Printers Pvt Ltd, starting in January 2015.
Muhammad Haseeb attended Darul Arqam School from 2008 to 2010. During this period, they focused on studying the Quran and did not pursue any specific degree or field of study.
This person is not in any offices
Derma Sciences
Derma Sciences is a Medical Devices company specializing in the field of Advanced Wound Care. Currently their major products are Medihoney, Algicell AG, Xtrasorb wound dressing, Bioguard and Mobility1. Their newest product DSC127 - an Angiotensin Analog - is currently in Phase II Pre-Clinical trials.